Top 50 Medical Startup Investors in Finland in October 2024
A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical startups based in Finland. We rank investors based on the number of investments they made in Medical companies from Finland. We update this investor list every month.Top 50 Medical Startup Investors in Finland in October 2024
Investor | Medical Finland investments |
---|---|
Finnvera Venture Capital | 7 |
Business Finland | 6 |
Lifeline Ventures | 5 |
Voima Ventures | 5 |
Innovestor | 4 |
Maki.vc | 4 |
Icebreaker.vc | 3 |
Reaktor Ventures | 3 |
Karolinska | 3 |
M Ventures | 3 |
Butterfly Ventures | 3 |
Novartis Venture Fund | 3 |
Inventure | 2 |
Springvest | 2 |
Novo Holdings | 2 |
Tesi | 2 |
Jyri Engestrom | 2 |
Vesalius Biocapital Partners | 2 |
Metsola Ventures | 2 |
Anssi Vanjoki | 2 |
XR Invest | 1 |
Samsung Venture Investment | 1 |
Kustaa Piha | 1 |
Nordea | 1 |
Athensmed | 1 |
Ali Omar | 1 |
SHS Capital | 1 |
Asko Schrey | 1 |
Petri Pöyhönen | 1 |
Sandwater | 1 |
Metaplanet | 1 |
Capricorn Partners | 1 |
Lynx Capital | 1 |
Marten Mickos | 1 |
Way to Wellville | 1 |
Gaingels | 1 |
Jukka Tapaninen | 1 |
MVM Life Science Partners | 1 |
Hadean Ventures | 1 |
Sunstone Life Science Ventures | 1 |
Cascara Ventures | 1 |
Ascend Capital Partners | 1 |
J12 | 1 |
Debiopharm Innovation Fund | 1 |
DigiTx Partners | 1 |
Visionplus | 1 |
Nuard Ventures | 1 |
Inveni Capital | 1 |
Cor Group | 1 |
HTGF | High-Tech Gruenderfonds | 1 |
Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.
Show more
Investment focus
- Software, Health Care, Information Technology
- Seed, Funding Round, Series A
- Finland, United States, Switzerland
Portfolio highlights
- Enfuce — Unlock growth with our card issuing solutions. Our expertise in issuer processing can turn your ambitious vision into a reality.
- Nordcloud — Nordcloud is a European leader in public cloud infrastructure solutions and cloud-native application services. Since 2011 we have completed more than 500 deployments to help our enterprise customers gain the maximum benefits of the cloud, including security, agility, scalability and overall cost-savings.
- Aurealis Pharma — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.
Show more
Investment focus
- Software, SaaS, Biotechnology
- Seed, Grant, Debt Financing
- Finland, United States, United Kingdom
Portfolio highlights
- QMill — QMill, with its innovative quantum algorithms for the noisy intermediate-scale quantum (NISQ) era, will usher in the era of practical quantum advantage.
- Root Signals — Root Signals lets you create, optimize and embed the needed evaluators into your code, so you can continuously monitor the behavior of LLM automations in production.
- Polku Therapeutics — Polku Therapeutics operates as a therapeutics company. Polku Therapeutics develops novel disease-halting therapies which provides new treatment options.
Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.
Show more
Investment focus
- Software, Health Care, E-Commerce
- Seed, Series A, Funding Round
- Finland, United States, United Kingdom
Portfolio highlights
- Droppe — Order work equipment directly from manufacturers. Support small businesses and source more responsibly from local and European manufacturers. Order from several suppliers at the same time with one shopping cart. Test samples for free and order products for your workplaces without extra hassle. Find nitrile gloves, protective clothing, work gloves, work accessories, disposable gloves, disinfectants, sanitizers and other supplies in one place.
- Risk Ledger — Risk Ledger ensures your supply chain security by providing tools to run and respond to cyber security-led, third-party risk management programmes at scale.
- Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more
Investment focus
- Biotechnology, Health Care, Medical Device
- Seed, Pre-Seed, Funding Round
- Finland, Sweden, Norway
Portfolio highlights
- NADMED — The standard of NAD measuring
- Betolar — Betolar is a new materials startup specialized in new geopolymer-based carbon-neutral construction materials for the construction industry and circular economy.
- Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more
Investment focus
- Software, Health Care, Manufacturing
- Seed, Funding Round, Series A
- Finland, Denmark, Sweden
Portfolio highlights
- Kausal — Kausal helps cities turn their climate goals into action through a digital platform that enables smarter collaboration around key data.
- Confidentialmind — The ConfidentialMind software stack enables you to integrate AI-solutions such as language models into your workflows and processes without data leaks to third parties. We will find a way to protect your data.
- Polku Therapeutics — Polku Therapeutics operates as a therapeutics company. Polku Therapeutics develops novel disease-halting therapies which provides new treatment options.
Maki.vc is an early-stage venture capital firm partnering with deep tech & brand-driven startups obsessed with challenging category norms.
Show more
Investment focus
- Software, E-Commerce, Information Technology
- Seed, Series A, Funding Round
- Finland, Germany, United Kingdom
Portfolio highlights
- CardioSignal — Access information about your heart health in just one minute using your phone.
- QMill — QMill, with its innovative quantum algorithms for the noisy intermediate-scale quantum (NISQ) era, will usher in the era of practical quantum advantage.
- Distance Technologies — Distance Technologies seeks to develop glasses-free XR applications
Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Pre-Seed, Seed, Series A
- Finland, Estonia, Sweden
Portfolio highlights
- LumiDB — LumiDB allows you to put all your 3D scan data, from point clouds to mesh models, into a single repository, accessible through a straightforward API. We provide an elegant API, optimized performance, and ease of use.
- Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
- Tab — Tab is the API-first company that enables smart receipts to arrive straight to your mobile bank app, all linked to your payment card. We help merchants deliver a seamless checkout experience and to unlock new avenues for post-sale engagement, banks to offer better user experiences & reducing customer support costs and consumers can wave goodbyeto lost receipts, tedious expense reporting processes and a more engaging banking experience.
Reaktor Ventures has moved to the next phase by focusing its efforts to actively supporting current portfolio companies. This means that the fund has ended its investment period and is not investing into new companies. Between 2013 and 2018 we have invested into 42 different companies and one early stage fund. We will naturally keep makingfollow-up investments to current portfolio companies.
Show more
Investment focus
- Software, Internet, Health Care
- Seed, Pre-Seed, Series A
- Finland, Germany, United States
Portfolio highlights
- Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
- Swappie — Buy refurbished iPhones at an affordable price - Swappie offers refurbished and cheap iPhones with a free 12-month Swappie warranty.
- Videoly — The easiest way for online retailers to get hand-picked and automatically embedded product videos.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Funding Round, Seed, Series A
- Sweden, Denmark, United States
Portfolio highlights
- PharmNovo — Latest News from PharmNovo. Learn more about pain, neuropathic pain, chronic pain. Treatment with our lead candidate PN6047. Therapy market, our networks. There is a huge unmet medical need for people suffering from chronic pain.
- OssDsign AB — Giving patients back the life they deserve, Catalyst nanosynthetic bone graft, orthobiologics
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Switzerland, United Kingdom
Portfolio highlights
- Anjuna — Anjuna confidential cloud software establishes a secure enclave that isolates and encrypts applications and data in runtime, at rest, and on the network for end-to-end data protection
- Formo — We're Formo, the future of dairy. Using micro fermentation, we create animal-free cheeses that humans love.
- NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.
Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.
Show more
Investment focus
- Health Care, Software, Information Technology
- Seed, Funding Round, Pre-Seed
- Finland, Sweden, Norway
Portfolio highlights
- RiACT — Software for robots. Real-time development platform for creators and users of flexible robot applications.
- 10Lines — 10Lines is developing autonomous parking lot marking robots and technological solutions to significantly increase productivity in the industry of pavement marking. Our solutions are helping striping businesses do their work much more productively with a smaller environmental footprint.
- Flow Computing — Flow's Parallel Processing Unit (PPU) gives 100X CPU performance for demanding applications, such as locally-hosted AI and general-purpose parallel computing.
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series B, Series A, Series C
- United States, Switzerland, United Kingdom
Portfolio highlights
- Hyku — Hyku Biosciences is developing the next generation of covalent medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
- Exsilio Therapeutics — Exsilio's method is based on naturally occurring genetic elements that can accurately insert new genes into cells via RNA intermediate templates. Exsilio employs predictive in-silico modeling and wet lab-based experiments to create such elements for accurate insertion of therapeutic genes into safe harbor regions of disease-relevant cells.
- Enterprise Therapeutics — Enterprise Therapeutics is a drug discovery company dedicated to the researchand development of novel therapies for the treatment of respiratory diseases.In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlyingmechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Series B
- Finland, Sweden, Denmark
Portfolio highlights
- Leya AI — Feel and sound like an English native in 3 months
- Steep — Business intelligence for modern companies. Steep lets anyone on your team stay on top of your data.
- Reveel — Say goodbye to paper maps, brochures, and outdated audio guides. Reveel offers digital solutions for destinations such as UNESCO sites, sights, museums, cities, hotels and parks, taking the visitor experience to the next level. Become part of the smart destination movement, enhance the visitor experience, and discover the future of travel.
The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.
Show more
Investment focus
- Biotechnology, Health Care, Analytics
- Series A, Funding Round, Seed
- Finland
Portfolio highlights
- Desentum — Allergen immunotherapy that is effective, safe, patient-friendly and approved by the regulatory authorities.
- Kuva Space — Kuva Space improves life on Earth through daily, space-borne hyperspectral imaging and AI. We offer Earth observation solutions for more sustainable business.
- Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Series B, Series C
- United States, Denmark, United Kingdom
Portfolio highlights
- Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
- Draupnir Bio — Draupnir Bio is developing new innovative therapies for patients.
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570
Show more
Investment focus
- Software, Manufacturing, Health Care
- Funding Round, Series A, Series B
- Finland, United States, Argentina
Portfolio highlights
- Seaber — Seaber is a cloud-based real-time planning, optimisation and communication solution for bulk cargo & vessels. Our solution improves the efficiency of bulk & break bulk charterers, shipowners & brokers through schedule planning and stakeholder communications over the lifecycle of a voyage.
- Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
- Basemark — Basemark: The automotive AR company - provider of software solutions and toolchains for automotive AR application development.
Jyri Engeström is an Investor and Partner of Yes VC. He attended Lancaster University
Show more
Investment focus
- Software, E-Commerce, Apps
- Seed, Angel, Series A
- United States, Finland, France
Portfolio highlights
- Jow — Jow is a grocery shopping app that simplifies shopping and gives advice of what to eat. This app offers free and simple recipes that adapt to the customer's taste. It automatically creates a customized menu with delicious recipes and fills the cart with all the ingredients necessary for cooking.Jow was founded in 2017 and is headquartered inParis, France.
- Spell — Operationalizing AI for NLP, Computer Vision, and Speech Recognition has never been easier
- Orchid Labs — Orchid Labs is an open-source project committed to ending surveillance and censorship on the internet. Orchid uses an overlay network built upon the existing internet, which is driven by a peer-to-peer tokenized bandwidth exchange, creating a more inclusive, liberated internet. Orchid Labs was founded in 2017 by Dr. Steven Waterhouse, Jay Freeman,Brian J. Fox, Gustav Simonsson, and Stephen Bell.
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- Belgium, Germany, The Netherlands
Portfolio highlights
- inHEART — inHEART is a spin-off from IHU Liryc and Inria, two top-tier research centers respectively in cardiac electrophysiology and digital science and technology, that develops software solutions for medical image analysis and cardiac modeling in heart rhythm disorders. inHEART vision is to make the bridge between radiology and cardiology to become aworldwide leader in image-guided diagnosis, therapy planning and navigation software solutions for heart rhythm disorders.
- Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
- Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
Metsola Ventures
Show more
Investment focus
- Medical, mHealth, Health Care
- Series A
- Finland
Portfolio highlights
- Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
- Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
As Executive Vice President and General Manager of Multimedia, Nokia, Anssi Vanjoki heads a business group that is responsible for developing Nokia Nseries multimedia computers and associated experiences and services. This fast growing segment of consumer electronics will shape our lives in a fundamental way. A highly respected brand authoritywith over 25 years of marketing experience, Anssi has been a driving force in Nokia's efforts to address the mobile markets. His work has focused on developing Nokia's brand durability, loyalty and continuity, while, at the same time, advancing Nokia's vision of a mobile world. Anssi joined Nokia in 1991 and was named Vice President, Sales, Nokia Mobile Phones, before his promotion in 1994 to Senior Vice President, Nokia Mobile Phones Europe and Africa. In 1998 he was made Executive Vice President, Nokia Mobile Phones Europe and Africa and became a member of the Group Executive Board of Nokia. In addition, in 1999, Anssi took responsibility for Nokia's Digital Convergence Unit and, in 2002, also headed up the Business Unit Management. He was appointed to his present position on January 1st 2004. Prior to joining Nokia, Anssi held a variety of management positions at 3M Corporation. Anssi is the Chairman of the Board of Amer Group, and was a member of the Governing Committee of the European Foundation for Quality Management 2001 - 2003. He is a Knight, 1st Class, of the Order of the White Rose of Finland. Anssi holds a master's degree in economics from the Helsinki School of Economics and Business Administration.
Show more
Investment focus
- Medical, Hardware, Health Care
- Angel, Series A
- Finland
Portfolio highlights
- HumanCharger — Humancharger Bright Light Headset
XR Invest is an investment firm focused on medtech and digital health early-stage start-ups.
Show more
Investment focus
- Medical Device, Sensor, Medical
- Series A, Series C, Funding Round
- Finland, United States
Portfolio highlights
- Augmedics — Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (XVS) system, is an augmented-reality surgical navigation system designed to allow surgeons tosee and navigate inside a patient’s body during complex procedures.
- Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Samsung Venture Investment is plays the role of driving the discovery and development of new businesses and technologies.
Show more
Investment focus
- Information Technology, Software, Health Care
- Series A, Series B, Seed
- South Korea, United States, India
Portfolio highlights
- Modapl — Modapl's objective is to make all mobility data available to everyone. It is developing a platform for exchanging mobility data. The platform will contain data generated by autos, IoT devices, and smartphones, as well as mobility data owned by businesses.
- BrickBio — BrickBio: Bioconjugation platform for site-specific, site-selective modification of antibodies and other proteins
- HMC Networks — Hmcnetworks leads service innovation, resolving the imbalance of information in the medical industry by using big data.
Healthcare business development, management, and investing. Very good knowledge on healthcare services and public health. Kustaa Piha is interested in new business and investment opportunities and better ways of producing excellent healthcare services.
Show more
Investment focus
- Health Care, Medical, mHealth
- Seed, Funding Round
- Finland
Portfolio highlights
- Sooma — Sooma provides unique therapy solutions that combine effectiveness with ease-of-use. Therapies are based on tDCS method.
- Klinik —
- Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
Nordea Bank is Denmark's second-largest bank and counts every fourth Dane among its customers. Through their nationwide network of some 340 branch offices and a broad range of self-service facilities, they are able to offer you a full scale of financial products and services, including Netbank, Online Investment, telephone banking and cashdispensers.
Show more
Investment focus
- FinTech, Financial Services, Banking
- Funding Round, Debt Financing, Seed
- Finland, Sweden, Norway
Portfolio highlights
- Tibber — Tibber is a digital electricity supplier that offers smart solutions to minimize their customers’ consumption and costs. Its vision is to make sustainable energy consumption simple and affordable for all households. Tibber's mission is to reduce the residential electricity consumption for European households by 20 %. Founded in Norway andSweden in 2016, the company has expanded its offer to Sweden and Germany where it powers hundreds of thousands of homes. Tibber replaces traditional utilities with smart technology, supplying its customers with renewable energy at fair and transparent prices. In addition, its app provides real-time analytics into energy usage, and pairs with a variety of smart home devices to reduce electricity consumption at home. The company sells tech-gadgets in their online store and recently was licensed to balance the main power grid in Sweden with EVs.
- Statzon — Make data-driven plans & faster decisions with a simple access to +1M datasets & market reports about 8,000 topics from +200 trusted data providers.
- Get It Done Now — GIDN is a Nigerian Fintech Company targeting medium and low income population for Loans and Financial products. GIDN has in addition a cashless, mobile based community marketplace, with more than 5k members, and aims to regulate the informal economy and facilitate the purchase of Services and Digital Products.
Athensmed Oy
Show more
Investment focus
- Health Care, Medical, mHealth
- Seed, Series A, Funding Round
- Finland
Portfolio highlights
- Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
- VideoVisit — VideoVisit is a Nordic health technology company, developing digital solutions for home care and healthcare sectors. They make healthcare available to everyone, anywhere and anytime, and strive to provide solutions that help people live independently at home for as long as possible. They collaborate with healthcare specialists to ensure that oursolutions are available to everyone.
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Ali Omar is a Member of the Finnish Business Angels Network. He attended Aalto University and the University of Oulu.
Show more
Investment focus
- Software, SaaS, Artificial Intelligence
- Seed, Pre-Seed, Angel
- Finland, United States, Estonia
Portfolio highlights
- Themo — Themo's innovation is an algorithm that optimizes the price of exchange electricity and the consumption of electricity. Themo offers an easy and environmentally friendly way to save on electricity consumed by heating.
- GoalProfit — GoalProfit is the world’s first low code retail optimization platform empowering retailers to build customized intelligence applications. It was founded by former IBM executives, Maxim Morozov and Oleg Sidorkin. GoalProfit is on a mission to make big data solutions available for all retailers and help them to survive in a new post-covid reality.
- Builderhead — Builderhead is a construction management software designed for real estate developers and general contractors. The software combines project development, procurement, and construction management into a streamlined pipeline. We bring an industry spesific Project Development CRM, Bid Management Tools and Project Management Software in one easy-to-useplatform which integrates easily with other most used software in the industry. Even thought the construction industry accounts for 13% of the world’s GDP, there's been a global problem of poor productivity within the industry as productivity growth has increased only 1% over the past 20 years. From the real estate developers and general contractors point of view, the biggest issue is the projects that turn unprofitable unexpectedly. One unprofitable project destroys the whole year profits and another one can bankrupt the entire company. Most of the decisions that affect the success of a project are made before construction begins, but still there are no smart tools available for that stage to help the construction companies avoid unprofitable projects. We solve this global problem by bringing the most critical steps to the success of a construction project on the same platform.
Mission With our investments, SHS Capital supports fast-growing companies in their mission to become European healthcare champions. Located in the …
Show more
Investment focus
- Health Care, Medical Device, Medical
- Funding Round, Series C, Series A
- Germany, Switzerland, France
Portfolio highlights
- MESI Medical — The MESI mTABLET provides predictive medical assessment with a wide selection of hardware modules, software extensions and different integration options.
- Dr.Dropin — Dr.Dropin an accessible and modern private health service that offers the vast majority of medical services at a fixed price.
- Simulands — Human grade cardiovascular simulators
Asko Schrey
Show more
Investment focus
- Medical, Health Care, Machine Learning
- Seed
- Finland
Portfolio highlights
- Zefort — Zefort is a powerful contract management software. Sign, store, share contracts and easily with your team. Set reminders and use a powerful search.
- MVision AI — MVision develops technology that improves the treatment of various types of cancer by using artificial intelligence and machine learning. The company has been built on the idea to be an impactful organisation by bringing AI assisted diagnosis and treatment to whoever needs it, especially in developing countries. This dramatically improves treatmentoutcome and saves money.The founding team consists of AI PhD’s, data platform architects and physicists with experience from companies such as Varian Medical Systems and GE healthcare.
Petri Pöyhönen
Show more
Investment focus
- Medical, Biotechnology, Medical Device
- Series A
- Finland
Portfolio highlights
- Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
We are Sandwater. Regeneration of our resources. Vitalizing healthcare & education. Improving life through technology.
Show more
Investment focus
- Apps, AgTech, Energy
- Series A, Seed
- Norway, Finland
Portfolio highlights
- Evyon — Eyvon is an electrical company that provides EV battery solutions to accelerate into a fully renewable future for everyone. The company's proprietary hardware and Battery Cloud ecosystem enable the conversion of EV batteries into high-quality, affordable, and plug-and-play battery energy storage systems.Eyvon's mission is to convertbattery waste into high-quality battery systems by repurposing discarded EV batteries. By leveraging a standardized and data-driven value chain, their ambition is to provide solutions at less than half the price of new ones.It was founded in 2020 and is based in Oslo, Norway.
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
- CardioSignal — Access information about your heart health in just one minute using your phone.
an early-stage investment firm making long-term bets on contrarians and leveraging the knowledge and network across sectors. We back mission-driven founders working on positively disruptive deep technologies.
Show more
Investment focus
- Artificial Intelligence, Software, Machine Learning
- Seed, Series A, Series B
- United States, United Kingdom, Estonia
Portfolio highlights
- Astranis — Four billion people still have no internet access. Astranis is here to change that. We're making small satellites for geostationary orbit, recently signed a contract to triple the satellite internet capacity of Alaska, and raised our Series A from Andreessen Horowitz.
- H3X Technologies — Ultra high power density integrated motor drives for electric aircraft.
- Perceptive Space — Perceptive Space is developing an AI-powered space weather platform that delivers predictions and decision intelligence to ensure safe and reliable operations in challenging space environments. By providing hyperlocal space weather forecasts and asset-specific insights into space weather impacts, Perceptive Space aims to help satellite operatorsand launch providers extend mission lifetimes and reduce operational downtimes and service interruptions.
Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds
Show more
Investment focus
- Biotechnology, Health Care, Software
- Funding Round, Series B, Series A
- Belgium, United States, The Netherlands
Portfolio highlights
- Chainels — The tenant experience app for every property in your portfolio. Save time, gain insights and collaborate with your tenants all in one place.
- VoxelSensors — Spatial and Empathic Computing. Bringing empathic abilities to XR and mobile devices by understanding user attention and intent.
- Electric Hydrogen — Electric Hydrogen designs and builds low-cost, high-efficiency green hydrogen systems to economically decarbonize industrial sectors like ammonia and steel
cross-border, healthcare, life science, investment, VC, China, US
Show more
Investment focus
- Therapeutics, Biotechnology, Pharmaceutical
- Series A
- Finland
Portfolio highlights
- Bone Index Finland — Bindex® is – in addition to DXA devices – the only device that can be used for osteoporosis diagnostics with international guidelines (ISCD) and the Finnish Current Care Guidelines (04/2014).Bindex® is applied by measuring the cortical thickness of tibia. The results, combined with other patient data, are used to estimate the hip region’sbone mineral density. Bone mineral density values (g/cm2) are normally only received via the large DXA devices used in hospitals.Bindex®’s quickness and simplicity make its use possible in high volume risk group screenings. It makes the identification of an osteoporosis risk possible before the first bone fracture has even occurred. Thus, it both improves the patient’s quality of life and saves on public health care expenses.
- Aurealis Therapeutics — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
Marten Mickos is the CEO of HackerOne, Inc. the leading vulnerability coordination and bug bounty platform. Previously Marten was the CEO of Eucalyptus Systems, acquired by Hewlett-Packard where he served as head of the cloud business. As the CEO of MySQL AB from 2001 to 2008, Marten grew that company from a garage start-up to the second largestopen source company in the world. Marten holds a M.Sc. in technical physics from Helsinki University of Technology in his native Finland.
Show more
Investment focus
- Software, Internet, Enterprise Software
- Seed, Series A, Convertible Note
- United States, Finland, Sweden
Portfolio highlights
- BrandBastion — The #1 choice for ad spenders and top brands. We provide 24/7 support by engaging with customers, removing harmful comments, and alerting you about issues.
- Queer Spaces — Spaces is a group chat platform for building queer communities, and the first app to serve the entirety of the LGBTQ+ spectrum.
- ArcticStartup — ArcticStartup is helping to build communities with uncapped opportunities through media, events, PR and consulting since 2007.Launched in 2007 by Antti Vilpponen and Miikka Kukkosuo as founding writers and getting out two-three articles a week, ArcticStartup quickly started gaining traction. In 2008 Ville Vesterinen and Karri Saarinen joinedthe founding team and ArcticStartup launched its own that were at first held in a small bar of Dubrovnik in Helsinki. Both the media and events started going international in 2009, expanding to the neighbouring Nordics & Baltics. This growth continued until 2012, when the company nearly shut-down as the founders wanted to move-on to other projects. At that point Dmitri Sarle and Greg Anderson took over the company and re-founded ArcticStartup with Jan Ameri joining very shortly.
Wellville is a 10-year national nonprofit project to achieve equitable wellbeing. We support the efforts of The Wellville 5: Five US communities.
Show more
Investment focus
- Software, Health Care, Medical
- Funding Round, Series B, Series A
- United States, Finland
Portfolio highlights
- Upbeat — Menang berapapun di PANEN33 pasti dibayar. PANEN33 merupakan situs slot terbesar dan terpercaya di Indonesia. Semua member PANEN33 sudah merasakan maxwin.
- Trimian — Startup based in Menlo Park, focusing on mobile apps. The name comes from 'tri-simian', referring to the three wise monkeys.
- Big Health — Our mission is to help millions back to good mental health. Our digital therapeutics are safe and effective non-drug alternatives for mental health.
Gaingels is a leading venture investment syndicate in support of diversity, inclusive of the LGBTQIA+ community and allies in the venture capital space.
Show more
Investment focus
- Software, Health Care, FinTech
- Seed, Series A, Series B
- United States, Canada, Mexico
Portfolio highlights
- VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
- Permanent — Permanent grows, supplies, & distributes regenerative, organic, & differentiated produce. We optimize cost, quality, & impact for foodservice, CPG, & retail.
- Vahan.ai — Vahan uses Artificial Intelligence to match job seekers with employers inside messaging apps
Jukka Tapaninen is an experienced IT business executive and a board member at Fimmic. Jukka also holds board positions at weVision, Addoro Ab, Findity and MeshWorks Wireless Oy.Jukka has a strong background in the IT industry on managing companies and business units globally. His leadership experience, from large companies like SAP and HP, aswell as from strong midsize companies has given him industry knowledge and excellent network within the strategic ecosystem and major customers. Jukka has experience in working in the United States, Singapore and multiple locations in Europe that have given him a good understanding on how business is done in different parts of the world.Jukka holds a M.Sc. degree from the Helsinki School of Economics.
Show more
Investment focus
- Medical, Software, Education
- Seed
- Finland
Portfolio highlights
- Aiforia — Aiforia provides software and services for pathologists, scientists and healthcare professionals to use artificial intelligence for image analysis.
MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Funding Round, Series B, Series C
- United States, United Kingdom, Switzerland
Portfolio highlights
- Icotec — Icotec develops and produces carbon fiber reinforced plastic implants for spine surgeries and accident treatments.
- Gynesonics — Gynesonics is a women’s healthcare company focused on the development of advanced incision-free solutions for the treatment of uterine conditions. Gynesonics serves customers worldwide. It was founded in 2005 and is headquartered in Redwood City, California.
- Nalu Medical — Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region.
The funds are backed by leading private and institutional investors.
Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Funding Round, Series B
- Sweden, Norway, Austria
Portfolio highlights
- SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Funding Round, Series B, Series A
- Denmark, Sweden, Switzerland
Portfolio highlights
- Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
- Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
96
Normal
0
false
false
false
EN-GB
X-NONE
X-NONE
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series A, Seed, Series B
- Germany, Finland, The Netherlands
Portfolio highlights
- Surgify — Surgify are currently preparing the commercialization of a novel technology for bone surgery at Aalto University with financial support from Tekes (Finnish Funding Agency for Innovation). To enable continuous communication with clinicians, they have been working in close cooperation with Neurosurgical Department of Helsinki University CentralHospital, part of HUS (The Hospital District of Helsinki and Uusimaa).
- ATRO Medical — ATRO Medical is a spin-out from DSM and Radboudumc and builds on the knowledge developed in the Public-Private Collaboration BioMedical Materials that started in 2010 with a consortium of universities, private companies, and financial support from the Dutch government. The collaboration between the clinical, biomechanical, and polymer expertise hascreated the base for the Trammpolin design and the development towards a prototype.
- microDimensions — microDimensions provides digital pathology software and services: image analysis, 3D histology reconstruction, protein multiplexing, stereology, image registration.
Founded by two Wall Street professionals in 2002 with the goal of making companies successful by helping them raise capital and improve their management standards. This was done by taking an active role in running these companies (at the Board level and operationally) and helping to secure strategic partnerships.Over USD 100 million in assetsgenerated from successful investments in China, and more recently in Europe. All invested funds come from our partners; no 3rd party money is managed. Since the partners are investing their own capital, they are dedicated to making their investments successful.Led by Monita Mo, one of the founders and a serial entrepreneur. Our partners have decades of experience across a wide range of industries and geographical regions. All investment partners have done business in Asia and bring an extensive network of contacts for our investments. Additionally, they have started, managed, and sold businesses and understand the challenges involved.See the need to share more developed technology to other markets, especially in China, where growth opportunities may be greater. That is why we are currently focusing on companies in Europe and other developed markets that have unique technologies that can be commercialized in their home markets, Asia, and the US.
Show more
Investment focus
- Health Care, Medical Device, Internet of Things
- Series A, Seed, Funding Round
- Finland, Austria, United States
Portfolio highlights
- piur imaging — PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules.
- Inflection.io — Marketing technology for product-led companies
- Nanoflex Robotics — Nanoflex Robotics develops a soft robotic system that precisely inserts specially made guidewires and catheters deep into the brain. The company provides patented magnetic navigation technology but also the necessary surgical devices. Nanoflex Robotics was established in May, 2021 in Zurich, Switzerland.
J12 Ventures invests early in innovative companies in the Nordics.
Show more
Investment focus
- Software, Artificial Intelligence, Machine Learning
- Seed, Pre-Seed, Series A
- Sweden, Germany, Portugal
Portfolio highlights
- Ayora — Transform your firm's realisation and lockup by giving your fee earners P&L management superpowers
- Buddywise — Gain control of your safety risks and empower your EHS teams to be truly data-driven. Use existing cameras to gather data, eliminate risks and react in real-time.
- Jeff — Jeff is a personalized loan broker that matches borrowers and lenders through alternative data. Jeff's mission is to help the unbanked to access financial services. In the absence of credit history and bank transactions, Jeff gathers alternative data from sources like smartphones, social media, behavioral patterns, geolocation, and other typesof digital footprint.Jeff then puts this information to good use and find ways on how alternative data points can prove creditworthiness and build trust, building new ways of accessing financing and evolving an alternative credit score.The company was founded in 2019 and is located in Riga, Latvia.
Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases
Show more
Investment focus
- Health Care, Biotechnology, Software
- Series A, Seed, Series B
- Switzerland, United States, France
Portfolio highlights
- Altis Labs — Altis Labs is the computational imaging company advancing precision medicine. We believe that medical imaging is the richest source of untapped information. Life sciences companies use our software platform, Nota, to accelerate all stages of clinical development. Trained on over 140 million longitudinal real-world images with associated clinicalinformation, our deep learning models predict clinically meaningful outcomes to quantify treatment effect more accurately.
- OmicsChart — OmicsChart is an oncology data company on a mission to revolutionize precision oncology by building a patient-centred cancer data ecosystem, consolidating scattered data, promoting transparency, and advancing clinical research with machine learning on real-world datasets. Our flagship product PREON is an analytics platform for cancer biologists.
- MedaSystems — Streamline patient and provider inquiries for Expanded Access or Compassionate Use with secure, 21st Century Cures Act compliant, cloud software.
At DigiTx Partners,we believe that the pace of change in healthcare will only accelerate in the coming years. We believe that there are many smart people with great insights and drive who are developing innovative technologies and solutions. We look forward to supporting innovative companies that will make a difference in our healthcareecosystem, from companies that will change how patients navigate the healthcare system, that will integrate the disparate elements that comprise both diagnosis and treatment, that will speed the development of more effective drugs and that will enhance and enable efficient and accurate physician-patient interaction. DigiTx Partners looks forward to investing in those digital health companies that strive to keep all of us in better health.
Show more
Investment focus
- Health Care, Artificial Intelligence, Medical
- Series A, Seed, Series B
- United States, Finland
Portfolio highlights
- Mightier — Learn calming strategies through games
- Rune Labs — Software and data platform for neuromodulation
- CardioSignal — Access information about your heart health in just one minute using your phone.
WE HELP YOU TO GROW FASTER!
Show more
Investment focus
- Software, Information Technology, Internet
- Seed, Funding Round, Series A
- Finland, United States, United Kingdom
Portfolio highlights
- Pebble — Pebble is a electric vehicle manufacturing startup.
- Transfluent — Professional translations for all business needs. Fast. Easy.
- BetterDoctor — BetterDoctor helps validate and deliver accurate provider data to health plans, health systems, and hundreds of other companies via its API — from startups to publicly traded ones. This ultimately helps achieve the mission of helping consumers find the healthcare they need.Today, BetterDoctor's data platform and APIs power 9 health plans,350 companies, 1,500 developers, helping millions of people find the right doctor each month. Health Plans BetterDoctor uses multi-modal outreach to drive providers to attest their information on BetterDoctor's online portal. API PartnersBetterDoctor brings transparency to doctor data. Their real-time platform, master database and API services enable everyone to add doctor data to their systems, websites and applications. Today, BetterDoctor API and data tools power health insurance companies, healthcare startups and doctor search tools. https://betterdoctor.com/developers
Nuard Ventures invests in innovative early stage companies.
Show more
Investment focus
- IaaS, Real Time, Predictive Analytics
- Seed, Funding Round
- Finland, Germany, United States
Portfolio highlights
- WARD — WARD is a fantasy sport game, where fans can watch their favourite eSports matches and predict what will happen in real time.WARD is a startup out of Berlin which has created a “pick and predict” real-time prediction smartphone game, where players can win real prizes. People love to watch e-sports. We believe on these occasions they still want tobe able to participate.However, until now no product has offered anything other than the ability to watch. There’s been no way for fans to spectate, participate, analyse and predict the outcomes of their favourite games.
- MVision AI — MVision develops technology that improves the treatment of various types of cancer by using artificial intelligence and machine learning. The company has been built on the idea to be an impactful organisation by bringing AI assisted diagnosis and treatment to whoever needs it, especially in developing countries. This dramatically improves treatmentoutcome and saves money.The founding team consists of AI PhD’s, data platform architects and physicists with experience from companies such as Varian Medical Systems and GE healthcare.
- Polka Dot Studio — Kalian Bisa Memasang Taruhan Online Dengan Sangat Mudah Dan Nyaman Di Situs DEWAHOKI Yang Sudah Resmi Di Indonesia
Inveni Capital is a venture capital management company focused on investments in early to growth stage life sciences companies.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Funding Round
- Finland, United Kingdom
Portfolio highlights
- BioSilta — BioSilta Ltd. is a privately-held company that utilizes its unique, proprietary EnBase® technology platform to develop innovative, reagent-based EnPresso® growth systems. When compared to conventional growth media, EnPresso growth systems significantly increase the yield of high quality biomolecules from microbial cultures.
- Onbone — Onbone Ltd is a Finnish innovative company working on the field of medical technology. The company develops and markets innovative and user-friendly Woodcast products for orthopaedic and traumatology use. Onbone Ltd has eleven employees and the products are sold in Finland, Germany, Sweden, Holland and Great Britain.
Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Seed, Pre-Seed, Series A
- Finland
Portfolio highlights
- Gosta Labs — Focus on care
- Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
- Nightingale Health — The most advanced health check for the health industry.
The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Show more
Investment focus
- Software, Information Technology, Biotechnology
- Seed, Series A, Funding Round
- Germany, Switzerland, United States
Portfolio highlights
- Samp — Samp accelerates modernization and de-risks contracts by connecting outdated drawings with current 3D reality captures of your facilities using our AI.
- become.1 — become.1 is an employee benefits platform that eliminates the complexity of tax regulations for employees.
- Symphera — An all-in-one surgical system that makes minimally-invasive procedures more efficient.
Investors by industry
Energy
Climate
Health Care
Gaming
Hardware
Artificial intelligence
Impact
Media (entertainment)
Proptech
Marketplace
Community
FinTech
Google
Consumer
Biotech
EdTech
Agriculture (agtech)
Sustainability
Venture Capital
Beauty
B2B
Photography
Finance
Real Estate
Big Data
Web3
Clean Energy
Oil and Gas
Video Games
Food and Beverage
Social Media
Publishing
Medical
Email
Art
Wellness
Music
Mobile
Franchise
Social Network
Local
Education
Internet
Digital Media
Construction
Manufacturing
eSports
Sports
Enterprise Software
Legal
Android
Platforms
Payments
Mobile Advertising
Biotechnology
Hospitality
Fitness
Travel
Recruiting
Cannabis
Wine And Spirits
Medical Device
Crowdfunding
Social
Automotive
CleanTech
Fashion
Transportation
Mobile Apps
InsurTech
Organic Food
Enterprise
Retail
Financial Services
Infrastructure
LGBT
Life Science
Theatre
Film
Non Profit
Renewable Energy
Sporting Goods
SaaS
Restaurants
Software
Social Impact
Celebrity
Blockchain
Cryptocurrency
Facebook
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Ireland
New Zealand
Canada
United States
Spain
Indonesia
Singapore
South Africa
Africa
Qatar
Europe
LATAM
Middle East
Sri Lanka
Asia
Armenia
Vietnam
China
Japan
Saudi Arabia
Brazil
Oceania
Czech Republic
Ecuador
Barbados
Costa Rica
Finland
Morocco
Malta
Mali
Belarus
Malaysia
France
Italy
Peru
Estonia
Lithuania
Hong Kong
Myanmar
Lebanon
Kuwait
Cayman Islands
Cambodia
Israel
Panama
Denmark
Mexico
Kazakhstan
Liberia
Gibraltar
Jersey
Philippines
Norway
Mauritius
Chile
Kenya
Liechtenstein
Nicaragua
Bermuda
Belize
Georgia
Turkey
Serbia
Rwanda
Greece
El Salvador
Venezuela
Ukraine
Portugal
Sierra Leone
Zimbabwe
Sweden
Taiwan
Senegal
Egypt
Uruguay
Uganda
Hungary
Tunisia
San Marino
Slovenia
Zambia
Uzbekistan
Ethiopia
Russian Federation
Faroe Islands
Algeria
Seychelles
Ghana
Thailand
Puerto Rico
Tajikistan
Togo
Belgium
Poland
Tanzania
Croatia
Dominican Republic
Bulgaria
Nigeria
Azerbaijan
Namibia
Iceland
Iraq
Bahamas
United Arab Emirates
Bahrain
Honduras
Bolivia
Luxembourg
Isle of Man
Albania
Grenada
Pakistan
Jordan
Romania
Argentina
Bangladesh
Latvia
Cyprus
Oman
Guatemala
Austria
Cameroon
Switzerland
Colombia
Marshall Islands
Investors in Finland by industry
Restaurants
Transportation
Financial Services
Big Data
Cryptocurrency
Finance
Food and Beverage
Media (entertainment)
Payments
Video Games
Medical
Medical Device
Sports
Fitness
Agriculture (agtech)
Social Media
Internet
Digital Media
Mobile
Music
Android
Blockchain
Clean Energy
Enterprise Software
Construction
Hospitality
Platforms
Travel
Biotechnology
Enterprise
Consumer
Health Care
Biotech
Climate
EdTech
Sustainability
Energy
SaaS
Impact
Proptech
Artificial intelligence
Community
Hardware
Gaming
Mobile Apps
Fashion
Web3
B2B
Life Science
Oil and Gas
Automotive
Manufacturing
Real Estate
Software
Franchise
CleanTech
Social Network
Wellness
Marketplace
FinTech
Renewable Energy
Education
Retail
Infrastructure